Oversonic Robotics has added three new shareholders as the Italian humanoid robot company tries to move RoBee further into factories, healthcare settings and the United States.
The company announced that STMicroelectronics, Fondazione ENEA Tech Biomedical and SpotInvest have acquired stakes in Oversonic. The new investors are expected to support the industrial development of RoBee, the company’s cognitive humanoid robot, while helping expand applications in manufacturing, healthcare and service automation.
RoBee is the center of the story. Oversonic describes it as the first certified cognitive humanoid robot designed to operate in complex environments. The robot is already working in several companies and is also involved in experimental hospital programs. Oversonic says RoBee is the only humanoid robot certified for use in both industrial and healthcare sectors.
That certification angle is important because humanoid robots are usually easy to show and hard to deploy. A robot walking across a stage is one thing. A robot working near people in a factory or healthcare setting has to meet a much higher bar for safety, reliability and usefulness.
STMicroelectronics brings a major industrial name into the deal. The semiconductor company is expected to support Oversonic’s industrial drive, technology development and advanced manufacturing push. Fabio Gualandris, president of quality, manufacturing and technology at STMicroelectronics, said automation, AI and robotics are key parts of future manufacturing and tied the investment to improving adaptability, safety and efficiency.
Fondazione ENEA Tech Biomedical is focused on Oversonic’s healthcare path. That could matter as humanoids move toward hospitals, care facilities and rehabilitation environments, where robots may eventually support patients, staff and routine operations. SpotInvest, tied to entrepreneur Marco Setti, is expected to open more application areas in services and process automation, including the food industry.
Oversonic already has other industrial and financial partners, including Comat, Datalogic and AVM SGR through the Cysero fund. The new shareholders strengthen that network and give the company more support as it tries to scale RoBee from advanced robot platform into a broader application infrastructure.
The United States is also a major part of the plan. Oversonic says it sees the U.S. as a natural outlet market for cognitive humanoid robotics and has already established a presence in Cincinnati and Los Angeles to support commercial, industrial and financial development.
That U.S. push makes sense. American companies are looking for robots that can work in real operating environments, not just prototypes that need constant babysitting. If RoBee can prove itself in manufacturing and healthcare, Oversonic could enter the U.S. market at a moment when humanoid robotics is getting serious attention from investors, manufacturers and automation buyers.
Oversonic was founded in 2020 in Brianza, Italy, and has a multidisciplinary team of about 70 people working across computer science, mechanics, electronics and artificial intelligence. The company says RoBee is built to support people in complex working environments while interacting with operators, machines and other robots through AI-based technologies.
Join the Discussion